» Articles » PMID: 28727729

Induction of Labor Versus Expectant Management of Large-for-gestational-age Infants in Nulliparous Women

Overview
Journal PLoS One
Date 2017 Jul 21
PMID 28727729
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: There is no apparent consensus on obstetric management, i.e., induction of labor or expectant management of women with suspected large-for-gestational-age (LGA)-fetuses.

Methods And Findings: To further examine the subject, a nationwide population-based cohort study from the Swedish Medical Birth Register in nulliparous non-diabetic women with singleton, vertex LGA (>90th centile) births, 1992-2013, was performed. Delivery of a live-born LGA infant induced at 38 completed weeks of gestation in non-preeclamptic pregnancies, was compared to those of expectant management, with delivery at 39, 40, 41, or 42 completed weeks of gestation and beyond, either by labor induction or via spontaneous labor. Primary outcome was mode of delivery. Secondary outcomes included obstetric anal sphincter injury, 5-minute Apgar<7 and birth injury. Multivariable logistic regression analysis was performed to control for potential confounding. We found that among the 722 women induced at week 38, there was a significantly increased risk of cesarean delivery (aOR = 1.44 95% CI:1.20-1.72), compared to those with expectant management (n = 44 081). There was no significant difference between the groups in regards to risk of instrumental vaginal delivery (aOR = 1.05, 95% CI:0.85-1.30), obstetric anal sphincter injury (aOR = 0.81, 95% CI:0.55-1.19), nor 5-minute Apgar<7 (aOR = 1.06, 95% CI:0.58-1.94) or birth injury (aOR = 0.82, 95% CI:0.49-1.38). Similar comparisons for induction of labor at 39, 40 or 41 weeks compared to expectant management with delivery at a later gestational age, showed increased rates of cesarean delivery for induced women.

Conclusions: In women with LGA infants, induction of labor at 38 weeks gestation is associated with increased risk of cesarean delivery compared to expectant management, with no difference in neonatal morbidity.

Citing Articles

Non-diabetic fetal macrosomia: outcomes of elective delivery versus expectant management.

Corbett G, Hunter S, Javaid A, McNamee E, OConnell M, Lindow S Ir J Med Sci. 2022; 192(3):1249-1257.

PMID: 35781860 PMC: 9251024. DOI: 10.1007/s11845-022-03076-w.


Prospective cohort study of induction of labor: Indications, outcome and postpartum hemorrhage.

Kumar B, Kumari S, Hughes S, Savill S Eur J Midwifery. 2021; 5:53.

PMID: 34825132 PMC: 8582328. DOI: 10.18332/ejm/142782.


Large for Gestational Age and Obesity-Related Comorbidities.

Hong Y, Lee J J Obes Metab Syndr. 2021; 30(2):124-131.

PMID: 34053939 PMC: 8277589. DOI: 10.7570/jomes20130.


Body composition and growth in full-term small for gestational age and large for gestational age Swedish infants assessed with air displacement plethysmography at birth and at 3-4 months of age.

Larsson A, Ottosson P, Tornqvist C, Olhager E PLoS One. 2019; 14(5):e0207978.

PMID: 31091240 PMC: 6519902. DOI: 10.1371/journal.pone.0207978.

References
1.
Marsal K, Persson P, Larsen T, Lilja H, Selbing A, Sultan B . Intrauterine growth curves based on ultrasonically estimated foetal weights. Acta Paediatr. 1996; 85(7):843-8. DOI: 10.1111/j.1651-2227.1996.tb14164.x. View

2.
Vasudevan C, Renfrew M, McGuire W . Fetal and perinatal consequences of maternal obesity. Arch Dis Child Fetal Neonatal Ed. 2010; 96(5):F378-82. DOI: 10.1136/adc.2009.170928. View

3.
Hogberg U, Larsson N . Early dating by ultrasound and perinatal outcome. A cohort study. Acta Obstet Gynecol Scand. 1998; 76(10):907-12. DOI: 10.3109/00016349709034900. View

4.
Gaudet L, Wen S, Walker M . The combined effect of maternal obesity and fetal macrosomia on pregnancy outcomes. J Obstet Gynaecol Can. 2014; 36(9):776-784. DOI: 10.1016/S1701-2163(15)30479-5. View

5.
Boulvain M, Senat M, Perrotin F, Winer N, Beucher G, Subtil D . Induction of labour versus expectant management for large-for-date fetuses: a randomised controlled trial. Lancet. 2015; 385(9987):2600-5. DOI: 10.1016/S0140-6736(14)61904-8. View